𝔖 Bobbio Scriptorium
✦   LIBER   ✦

50. The pharmacological chaperone AT1001 and treatment of Fabry disease

✍ Scribed by Richie Khanna; Elfrida R. Benjamin; Rebecca Soska; Yi Lun; Sheela A. Sitaraman; David J. Palling; David J. Lockhart; Kenneth J. Valenzano

Book ID
116988235
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
42 KB
Volume
93
Category
Article
ISSN
1096-7192

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Second-Generation Iminoxylitol-Based Pha
Second-Generation Iminoxylitol-Based Pharmacological Chaperones for the Treatment of Gaucher Disease
✍ Farah OulaΓ―di; Sophie Front-Deschamps; Dr. Estelle Gallienne; Dr. Eric Lesellier πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 360 KB

## Abstract A series of __O__‐alkyl iminoxylitol derivatives was synthesized and evaluated as β‐glucocerebrosidase (GCase) inhibitors. This structure–activity study shows a dramatic influence of the position of the alkyl chain (α‐C1, O2, O3, or O4) on human GCase inhibition. Remarkably, 1,2‐shift o